Literature DB >> 16809784

Constitutive ALK5-independent c-Jun N-terminal kinase activation contributes to endothelin-1 overexpression in pulmonary fibrosis: evidence of an autocrine endothelin loop operating through the endothelin A and B receptors.

Xu Shi-Wen1, Fernando Rodríguez-Pascual, Santiago Lamas, Alan Holmes, Sarah Howat, Jeremy D Pearson, Michael R Dashwood, Roland M du Bois, Christopher P Denton, Carol M Black, David J Abraham, Andrew Leask.   

Abstract

The signal transduction mechanisms generating pathological fibrosis are almost wholly unknown. Endothelin-1 (ET-1), which is up-regulated during tissue repair and fibrosis, induces lung fibroblasts to produce and contract extracellular matrix. Lung fibroblasts isolated from scleroderma patients with chronic pulmonary fibrosis produce elevated levels of ET-1, which contribute to the persistent fibrotic phenotype of these cells. Transforming growth factor beta (TGF-beta) induces fibroblasts to produce and contract matrix. In this report, we show that TGF-beta induces ET-1 in normal and fibrotic lung fibroblasts in a Smad-independent ALK5/c-Jun N-terminal kinase (JNK)/Ap-1-dependent fashion. ET-1 induces JNK through TAK1. Fibrotic lung fibroblasts display constitutive JNK activation, which was reduced by the dual ETA/ETB receptor inhibitor, bosentan, providing evidence of an autocrine endothelin loop. Thus, ET-1 and TGF-beta are likely to cooperate in the pathogenesis of pulmonary fibrosis. As elevated JNK activation in fibrotic lung fibroblasts contributes to the persistence of the myofibroblast phenotype in pulmonary fibrosis by promoting an autocrine ET-1 loop, targeting the ETA and ETB receptors or constitutive JNK activation by fibrotic lung fibroblasts is likely to be of benefit in combating chronic pulmonary fibrosis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16809784      PMCID: PMC1592704          DOI: 10.1128/MCB.00625-06

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  60 in total

Review 1.  Myofibroblasts and mechano-regulation of connective tissue remodelling.

Authors:  James J Tomasek; Giulio Gabbiani; Boris Hinz; Christine Chaponnier; Robert A Brown
Journal:  Nat Rev Mol Cell Biol       Date:  2002-05       Impact factor: 94.444

2.  CTGF and SMADs, maintenance of scleroderma phenotype is independent of SMAD signaling.

Authors:  A Holmes; D J Abraham; S Sa; X Shiwen; C M Black; A Leask
Journal:  J Biol Chem       Date:  2001-01-04       Impact factor: 5.157

3.  Localisation of transforming growth factor beta1 and beta3 mRNA transcripts in normal and fibrotic human lung.

Authors:  R K Coker; G J Laurent; P K Jeffery; R M du Bois; C M Black; R J McAnulty
Journal:  Thorax       Date:  2001-07       Impact factor: 9.139

4.  Transforming growth Factor-beta1 induces phenotypic modulation of human lung fibroblasts to myofibroblast through a c-Jun-NH2-terminal kinase-dependent pathway.

Authors:  S Hashimoto; Y Gon; I Takeshita; K Matsumoto; S Maruoka; T Horie
Journal:  Am J Respir Crit Care Med       Date:  2001-01       Impact factor: 21.405

Review 5.  Transforming growth factor-beta and connective tissue growth factor: key cytokines in scleroderma pathogenesis.

Authors:  C P Denton; D J Abraham
Journal:  Curr Opin Rheumatol       Date:  2001-11       Impact factor: 5.006

6.  Contribution of activin receptor-like kinase 5 (transforming growth factor beta receptor type I) signaling to the fibrotic phenotype of scleroderma fibroblasts.

Authors:  Yunliang Chen; Xu Shi-wen; Mark Eastwood; Carol M Black; Christopher P Denton; Andrew Leask; David J Abraham
Journal:  Arthritis Rheum       Date:  2006-04

7.  Functional characterization of transforming growth factor beta signaling in Smad2- and Smad3-deficient fibroblasts.

Authors:  E Piek; W J Ju; J Heyer; D Escalante-Alcalde; C L Stewart; M Weinstein; C Deng; R Kucherlapati; E P Bottinger; A B Roberts
Journal:  J Biol Chem       Date:  2001-03-21       Impact factor: 5.157

8.  Smad3/AP-1 interactions control transcriptional responses to TGF-beta in a promoter-specific manner.

Authors:  F Verrecchia; L Vindevoghel; R J Lechleider; J Uitto; A B Roberts; A Mauviel
Journal:  Oncogene       Date:  2001-06-07       Impact factor: 9.867

9.  CTGF expression in mesangial cells: involvement of SMADs, MAP kinase, and PKC.

Authors:  Youjun Chen; Ingrid E Blom; Susan Sa; Roel Goldschmeding; David J Abraham; Andrew Leask
Journal:  Kidney Int       Date:  2002-10       Impact factor: 10.612

10.  SB-431542 is a potent and specific inhibitor of transforming growth factor-beta superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7.

Authors:  Gareth J Inman; Francisco J Nicolás; James F Callahan; John D Harling; Laramie M Gaster; Alastair D Reith; Nicholas J Laping; Caroline S Hill
Journal:  Mol Pharmacol       Date:  2002-07       Impact factor: 4.436

View more
  68 in total

1.  Survivin expression induced by endothelin-1 promotes myofibroblast resistance to apoptosis.

Authors:  Jeffrey C Horowitz; Iyabode O Ajayi; Priya Kulasekaran; David S Rogers; Joshua B White; Sarah K Townsend; Eric S White; Richard S Nho; Peter D R Higgins; Steven K Huang; Thomas H Sisson
Journal:  Int J Biochem Cell Biol       Date:  2011-10-25       Impact factor: 5.085

Review 2.  The role of connective tissue growth factor (CTGF/CCN2) in skeletogenesis.

Authors:  John A Arnott; Alex G Lambi; Christina Mundy; Honey Hendesi; Robin A Pixley; Thomas A Owen; Fayez F Safadi; Steven N Popoff
Journal:  Crit Rev Eukaryot Gene Expr       Date:  2011       Impact factor: 1.807

3.  Transforming growth factor-β regulates endothelin-1 signaling in the newborn mouse lung during hypoxia exposure.

Authors:  Nelida Olave; Teodora Nicola; Wei Zhang; Arlene Bulger; Masheika James; Suzanne Oparil; Yiu-Fai Chen; Namasivayam Ambalavanan
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2012-01-27       Impact factor: 5.464

4.  Rac1 expression by fibroblasts is required for tissue repair in vivo.

Authors:  Shangxi Liu; Mohit Kapoor; Andrew Leask
Journal:  Am J Pathol       Date:  2009-04-06       Impact factor: 4.307

5.  GSK-3beta in mouse fibroblasts controls wound healing and fibrosis through an endothelin-1-dependent mechanism.

Authors:  Mohit Kapoor; Shangxi Liu; Xu Shi-wen; Kun Huh; Matthew McCann; Christopher P Denton; James R Woodgett; David J Abraham; Andrew Leask
Journal:  J Clin Invest       Date:  2008-10       Impact factor: 14.808

6.  Genomic differences distinguish the myofibroblast phenotype of distal lung fibroblasts from airway fibroblasts.

Authors:  Xiuxia Zhou; Wei Wu; Haizhen Hu; Jadranka Milosevic; Kazuhisa Konishi; Naftali Kaminski; Sally E Wenzel
Journal:  Am J Respir Cell Mol Biol       Date:  2011-07-14       Impact factor: 6.914

7.  alpha2-antiplasmin is associated with the progression of fibrosis.

Authors:  Yosuke Kanno; Eri Kawashita; Misato Minamida; Aki Kaneiwa; Kiyotaka Okada; Shigeru Ueshima; Osamu Matsuo; Hiroyuki Matsuno
Journal:  Am J Pathol       Date:  2009-12-11       Impact factor: 4.307

8.  Correlation between congenital heart disease complicated with pulmonary artery hypertension and circulating endothelial cells as well as endothelin-1.

Authors:  Xiaofei Li; Jun Qiu; Min Pan; Dongdong Zheng; Yamin Su; Meifang Wei; Xiangqing Kong; Wei Sun; Jiahua Zhu
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

9.  Endothelin-1 and transforming growth factor-beta1 independently induce fibroblast resistance to apoptosis via AKT activation.

Authors:  Priya Kulasekaran; Casey A Scavone; David S Rogers; Douglas A Arenberg; Victor J Thannickal; Jeffrey C Horowitz
Journal:  Am J Respir Cell Mol Biol       Date:  2009-02-02       Impact factor: 6.914

10.  Towards an anti-fibrotic therapy for scleroderma: targeting myofibroblast differentiation and recruitment.

Authors:  Andrew Leask
Journal:  Fibrogenesis Tissue Repair       Date:  2010-05-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.